Non-papillary urothelial lesions of the urinary bladder: Morphological classification and immunohistochemical markers

被引:0
作者
Petraki, Constantina D. [1 ]
Sfikas, Constantinos P. [2 ]
机构
[1] Evangelismos Med Ctr, Renal Pathol Dept, Athens, Greece
[2] Helena Venizelou Hosp, Dept Pathol, Athens, Greece
来源
IN VIVO | 2008年 / 22卷 / 04期
关键词
non-papillary lesions; urothelium; urinary bladder; immunohistochemistry; review;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In the past quarter century, several nomenclature systems for non-papillary urothelial lesions of the urinary bladder have been proposed. The 1998 World Health Organization and International Society of Urological Pathology (WHO/ISUP) classification recommended a four-tier system for the subdivision of flat intraepithelial lesions of the bladder. This classification was adopted by the WHO in 1999 and revised in 2004. In 2002, a more detailed classification of flat urothelial lesions was based on the Ancona International Consultation. Each of these lesions was defined with strict morphological criteria to provide more accurate information to urologists in managing patients. However, immunohistochemical markers including proliferation markers, cytoskeletal proteins, growth factors and their related receptors, cell adhesion molecules and oncogene proteins are increasingly being used in order to differentiate histologically similar lesions.
引用
收藏
页码:493 / 501
页数:9
相关论文
共 39 条
[1]  
Amin MB, 1997, SEMIN DIAGN PATHOL, V14, P84
[2]   Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications [J].
Baithun, SI ;
Naase, M ;
Blanes, A ;
Diaz-Cano, SJ .
VIRCHOWS ARCHIV, 2001, 438 (03) :289-297
[3]  
Baud E, 1998, INT J CANCER, V77, P821, DOI 10.1002/(SICI)1097-0215(19980911)77:6<821::AID-IJC3>3.3.CO
[4]  
2-M
[5]  
Cheng L, 2000, CANCER, V88, P625, DOI 10.1002/(SICI)1097-0142(20000201)88:3<625::AID-CNCR20>3.3.CO
[6]  
2-1
[7]   Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma - An immunohistochemical study [J].
Chow, NH ;
Liu, HS ;
Yang, HB ;
Chan, SH ;
Su, IJ .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1997, 430 (06) :461-466
[8]   The World Health Organization International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder [J].
Epstein, JI ;
Amin, MB ;
Reuter, VR ;
Mostofi, FK .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (12) :1435-1448
[9]   Use of markers in defining urothelial premalignant and malignant conditions [J].
Grossman, HB ;
Schmitz-Dräger, B ;
Fradet, Y ;
Tribukait, B .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 :94-104
[10]   Cytokeratin 20 as an objective marker of urothelial dysplasia [J].
Harnden, P ;
Eardley, I ;
Joyce, AD ;
Southgate, J .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (06) :870-875